![](/img/cover-not-exists.png)
Repaglinide has more beneficial effect on cardiovascular risk factors than glimepiride: data from meal-test study
MR Rizzo, M Barbieri, R Grella, N Passariello, G PaolissoVolume:
31
Year:
2005
DOI:
10.1016/s1262-3636(07)70192-1
File:
PDF, 104 KB
2005